COST-EFFECTIVENESS ANALYSIS OF PATIROMER IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION FOR THE TREATMENT OF HYPERKALEMIA: ANALYSIS OF THE DIAMOND CLINICAL TRIAL

被引：0
|
作者：
Stawowczyk, E. [1 ]
Turner, M. [1 ]
Lewis, R. D. [1 ]
Lloyd, I. T. [1 ]
Ruiz, O. [2 ]
Serna, Ramirez De Arellano A. [3 ]
机构：
[1] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
[2] CSL Vifor, Barcelona, Spain
[3] CSL Vifor, Zurich, Switzerland
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE457
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [1] Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
    Butler, Javed
    Anker, Stefan D.
    Lund, Lars H.
    Coats, Andrew J. S.
    Filippatos, Gerasimos
    Siddiqi, Tariq Jamal
    Friede, Tim
    Fabien, Vincent
    Kosiborod, Mikhail
    Metra, Marco
    Pina, Ileana L.
    Pinto, Fausto
    Rossignol, Patrick
    van der Meer, Peter
    Bahit, Cecilia
    Belohlavek, Jan
    Boehm, Michael
    Brugts, Jasper J.
    Cleland, John G. F.
    Ezekowitz, Justin
    Bayes-Genis, Antoni
    Gotsman, Israel
    Goudev, Assen
    Khintibidze, Irakli
    Lindenfeld, Joann
    Mentz, Robert J.
    Merkely, Bela
    Montes, Eliodoro Castro
    Mullens, Wilfried
    Nicolau, Jose C.
    Parkhomenko, Aleksandr
    Ponikowski, Piotr
    Seferovic, Petar M.
    Senni, Michele
    Shlyakhto, Evgeny
    Cohen-Solal, Alain
    Szecsody, Peter
    Jensen, Klaus
    Dorigotti, Fabio
    Weir, Matthew R.
    Pitt, Bertram
    EUROPEAN HEART JOURNAL, 2022, 43 (41) : 4362 - 4373
  • [2] Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
    Mark Bounthavong
    Javed Butler
    Chantal M. Dolan
    Jeffrey D. Dunn
    Kathryn A. Fisher
    Nina Oestreicher
    Bertram Pitt
    Paul J. Hauptman
    David L. Veenstra
    PharmacoEconomics, 2018, 36 : 1463 - 1473
  • [3] Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
    Bounthavong, Mark
    Butler, Javed
    Dolan, Chantal M.
    Dunn, Jeffrey D.
    Fisher, Kathryn A.
    Oestreicher, Nina
    Pitt, Bertram
    Hauptman, Paul J.
    Veenstra, David L.
    PHARMACOECONOMICS, 2018, 36 (12) : 1463 - 1473
  • [4] Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
    Mark Bounthavong
    Javed Butler
    Chantal M. Dolan
    Jeffrey D. Dunn
    Kathryn A. Fisher
    Nina Oestreicher
    Bertram Pitt
    Paul J. Hauptman
    David L. Veenstra
    PharmacoEconomics, 2019, 37 : 1071 - 1071
  • [5] Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis
    Naves, Marcio Coutinho Xavier
    Amato, Angelica Amorim
    Zimmermann, Ivan Ricardo
    Peixoto, Henry Maia
    LANCET REGIONAL HEALTH-AMERICAS, 2025, 42
  • [6] A COST-EFFECTIVENESS ANALYSIS OF PATIROMER FOR THE TREATMENT OF HYPERKALEMIA IN SPAIN
    Gonzalez-Juanatey, J. R.
    Gonzalez-Franco, A.
    de-Sequera-Ortiz, P.
    Valls, M.
    Serna, Ramirez de Arellano A.
    Pomares, E.
    Nieves, D.
    VALUE IN HEALTH, 2022, 25 (01) : S94 - S95
  • [7] Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States
    Reifsnider, Odette S.
    Tafazzoli, Ali
    Linden, Stephan
    Ishak, Jack
    Rakonczai, Pal
    Stargardter, Matthew
    Kuti, Effie
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [8] Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction
    Parizo, Justin T.
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua A.
    Khush, Kiran K.
    Spertus, John A.
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    JAMA CARDIOLOGY, 2021, 6 (08) : 926 - 935
  • [9] A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
    Ramon Gonzalez-Juanatey, Jose
    Gonzalez-Franco, Alvaro
    de Sequera, Patricia
    Valls, Marta
    Ramirez de Arellano, Antonio
    Pomares, Elisenda
    Nieves, Diana
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 640 - 649
  • [10] Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial
    Chew, Derek S.
    Li, Yanhong
    Bigelow, Robert
    Cowper, Patricia A.
    Anstrom, Kevin J.
    Daniels, Melanie R.
    Davidson-Ray, Linda
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Armstrong, Paul W.
    Mark, Daniel B.
    CIRCULATION, 2023, 148 (14) : 1087 - 1098
12345